DrugPatentWatch Database Preview
Litigation Details for Cephalon Inc. v. Watson Pharmaceuticals Inc. (D. Del. 2009)
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Cephalon Inc. v. Watson Pharmaceuticals Inc. (D. Del. 2009)
| Docket | Start Trial | Date Filed | 2009-09-25 |
| Court | District Court, D. Delaware | Date Terminated | 2011-03-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | Plaintiff | Referred To | |
| Parties | CEPHALON INC.; WATSON LABORATORIES INC.; WATSON PHARMA INC.; WATSON PHARMACEUTICALS INC. | ||
| Patents | 4,671,953; 6,200,604; 6,264,981; 6,974,590; 7,834,020 | ||
| Attorneys | Laura D. Hatcher; Steven J. Fineman; William J. Marsden , Jr. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Cephalon Inc. v. Watson Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , and Start Trial .
Biologic Drugs cited in Cephalon Inc. v. Watson Pharmaceuticals Inc.
The biologic drug covered by the patents cited in this case is Start Trial .
Details for Cephalon Inc. v. Watson Pharmaceuticals Inc. (D. Del. 2009)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2009-09-25 | 1 | Complaint | 25 delivery is disclosed in U.S. Pat. No. 4,671,953 to Stanley, …infringement of United States Patent No. 6,264,981 B1 ("the '981 patent") under 28 U.S.C. §§… THE PATENT IN SUIT 15. On July 24, 2001, the '981 patent titled "Oral…Application prior to patent expiry would constitute infringement of the '981 patent. 21. …United States Patent (10) Patent No.: | External link to document |
| 2010-09-30 | 155 | claims of U.S, Patent Nos. 6,264,981 (“the ’981 patent”), 6,200,604 (“the ’604 patent”], and 6,974,590…quot; The Orange Book Patents ....................... 287 IV, THE ORANGE BOOK PATENTS ARE N()'I` ENABLEI…regarding the Orange Bool< patents, Plaintifts argue: “[A]s the Khan]cari patents detaii, the probiem addressed…OF THE ’981 PATENT ARE OBV'IOUS. To invalidate the asserted claims of the ’981 patent, the Court …same “solid solution" as the ’98| patent because both patents disclose the same manufacturing process | External link to document | |
| 2011-03-24 | 194 | '981 patent are obvious in view of Stanley in combination with U.S. Patent No. 4,671,953 (the "… U.S. Patent Nos. 6,200,604 (lithe '604 patent") and 6,974,590 (lithe '590 patent")…quot;) is the owner of U.S. Patent No. 6,264,981 ("the '981 patent"). Cephalon is the holder… (collectively, the "Khankari patents"), which patents were listed in the Orange Book in connection…Act for a drug claimed in a patent or the use of which is claimed in a patent[.]"). to 28 U.S.C. § | External link to document | |
| 2011-03-24 | 197 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,264,981 B1. (nmf) (Entered:…2009 24 March 2011 1:09-cv-00724-SLR Patent Plaintiff District Court, D. | External link to document | |
| 2009-11-12 | 25 | for infringement of United States Patent No. 6,264,981 (“the ’981 patent”). Plaintiff admits that this Court…Judgment of Noninfringement of United States Patent No. 6,264,981 B1 42. Plaintiff incorporates by reference…Judgment of Noninfringement of United States Patent No. 6,264,981 B1 45. Plaintiff incorporates by reference… Judgment of Invalidity of United States Patent No. 6,264,981 Bl 47. Plaintiff incorporates by reference…Defendants’ liability for infringement of the ’981 patent. Plaintiff denies the remaining allegations of | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
